MXPA05011775A - Sulfonamidas y pirazolamidas como moduladores de canal de sodio. - Google Patents

Sulfonamidas y pirazolamidas como moduladores de canal de sodio.

Info

Publication number
MXPA05011775A
MXPA05011775A MXPA05011775A MXPA05011775A MXPA05011775A MX PA05011775 A MXPA05011775 A MX PA05011775A MX PA05011775 A MXPA05011775 A MX PA05011775A MX PA05011775 A MXPA05011775 A MX PA05011775A MX PA05011775 A MXPA05011775 A MX PA05011775A
Authority
MX
Mexico
Prior art keywords
formula
sulfonamides
pyrazole
amides
sodium channel
Prior art date
Application number
MXPA05011775A
Other languages
English (en)
Spanish (es)
Inventor
Lei Shi
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/427,847 external-priority patent/US20040220170A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA05011775A publication Critical patent/MXPA05011775A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA05011775A 2003-05-01 2004-04-29 Sulfonamidas y pirazolamidas como moduladores de canal de sodio. MXPA05011775A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/427,847 US20040220170A1 (en) 2003-05-01 2003-05-01 Pyrazole-amides and sulfonamides as sodium channel modulators
PCT/US2004/013530 WO2004099154A2 (fr) 2003-05-01 2004-04-29 Pyrazole-amides et sulfonamides modulateurs des canaux sodiques

Publications (1)

Publication Number Publication Date
MXPA05011775A true MXPA05011775A (es) 2006-02-17

Family

ID=35529848

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011775A MXPA05011775A (es) 2003-05-01 2004-04-29 Sulfonamidas y pirazolamidas como moduladores de canal de sodio.

Country Status (4)

Country Link
EP (1) EP1620405A2 (fr)
JP (1) JP2006525355A (fr)
CA (1) CA2525325A1 (fr)
MX (1) MXPA05011775A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
US8183381B2 (en) * 2007-07-19 2012-05-22 Metabolex Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
US8410127B2 (en) 2009-10-01 2013-04-02 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
WO2012177263A1 (fr) * 2011-06-24 2012-12-27 Intra-Cellular Therapies, Inc. Composés et procédés de prophylaxie et de traitement concernant des antagonistes de récepteur nicotinique
HUE040489T2 (hu) * 2014-06-03 2019-03-28 Idorsia Pharmaceuticals Ltd Pirazolvegyületek és alkalmazásuk t-típusú kalciumcsatorna-blokkolókként
JP2019504840A (ja) * 2016-01-28 2019-02-21 ソルヴェイ（ソシエテ アノニム） ハロゲン置換ジケトン、ピラゾール化合物およびピラゾール化合物の製造方法
US10292983B2 (en) 2016-08-03 2019-05-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE443698T1 (de) * 1996-12-23 2009-10-15 Bristol Myers Squibb Pharma Co Stickstoffhaltige heterocyclen als faktor xa- hemmer
BR9810151A (pt) * 1997-06-19 2000-08-08 Du Pont Pharm Co Composto, composição farmacêutica e método para tratamento ou prevenção de uma desordem tromoboembólica
IL136637A0 (en) * 1997-12-22 2001-06-14 Du Pont Pharm Co Nitrogen containing heteroaromatics with ortho-substituted pi's as factor xa inhibitors
CA2373510A1 (fr) * 1999-05-12 2000-11-23 Ortho-Mcneil Pharmaceutical, Inc. Carboxamides de pyrazole utiles pour le traitement de l'obesite et d'autres troubles
IL148698A0 (en) * 1999-09-17 2002-09-12 Cor Therapeutics Inc INHIBITORS OF FACTOR Xa
CA2409827C (fr) * 2000-05-22 2010-06-01 Aventis Pharmaceuticals Products Inc. Derives d'arylmethylamine utilises comme inhibiteurs de la tryptase
US6604974B2 (en) * 2000-12-22 2003-08-12 Thomson Licensing S.A. Method and apparatus for applying crosswires to a tension focus mask
MXPA04012959A (es) * 2002-06-29 2005-05-16 Zentaris Gmbh Arilcarbonilpiperacinas y heteroarilcarbonilpiperacinas y su uso para tratamiento de enfermedades de tumor benigno y maligno.
GB0226178D0 (en) * 2002-11-11 2002-12-18 Johnson Matthey Plc Desulphurisation
AU2004218260A1 (en) * 2003-01-28 2004-09-16 Aventis Pharma S.A. N-aryl heteroaromatic products, compositions containing same and use thereof

Also Published As

Publication number Publication date
EP1620405A2 (fr) 2006-02-01
JP2006525355A (ja) 2006-11-09
CA2525325A1 (fr) 2004-11-18

Similar Documents

Publication Publication Date Title
WO2004099154A3 (fr) Pyrazole-amides et sulfonamides modulateurs des canaux sodiques
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
NZ527081A (en) Aniline derivatives useful as phosphodiesterase 4 inhibitors
NZ514095A (en) Amide compounds and medicinal use thereof
NZ589670A (en) Pyrrolidine inhibitors of iap
TW200420558A (en) Amide compounds
RU95122612A (ru) 4-аминопиридины, способ их получения, содержащие эти соединения лекарственные средства
WO2004010949A3 (fr) Composes actifs dans la signalisation de sphingosine 1-phosphate
PT1585739E (pt) Arilciclopropilacetamidas substitu?das como activadores da glucocinase
SG160195A1 (en) N-phenyl-2-pyrimidine-amine derivatives
AP1902A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
MXPA04004500A (es) 1,4-benzodiazepinas sustituidas y usos de las mismas para tratamiento del cancer.
MXPA03007248A (es) Quinazolinas como inhibidores de mmp-13.
MY141504A (en) Gamma secretase inhibitors
IL176075A0 (en) Process for fluorocytidine derivatives
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
WO2004013100A3 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
CY1108652T1 (el) Παραγωγα μορφολινυλ-ουριας για χρηση στη θεραπεια φλεγμονωδων ασθενειων
MXPA05007296A (es) Compuestos de (2-carboxamido)(3-amino)tiofeno.
IS7893A (is) Perindópríl
MXPA05011775A (es) Sulfonamidas y pirazolamidas como moduladores de canal de sodio.
CA3191532A1 (fr) Composes destines a eliminer le cancer mutant de l'egfr et leur utilisation pharmaceutique
PT1202959E (pt) Aminobenzofenonas como inibidores de il-1-beta e tnf-alfa
MY135191A (en) Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
WO2006029154A3 (fr) Nouveaux composes

Legal Events

Date Code Title Description
FA Abandonment or withdrawal